142 related articles for article (PubMed ID: 24969798)
1. Validated competing event model for the stage I-II endometrial cancer population.
Carmona R; Gulaya S; Murphy JD; Rose BS; Wu J; Noticewala S; McHale MT; Yashar CM; Vaida F; Mell LK
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):888-98. PubMed ID: 24969798
[TBL] [Abstract][Full Text] [Related]
2. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study.
Mell LK; Carmona R; Gulaya S; Lu T; Wu J; Saenz CC; Vaida F
J Natl Cancer Inst; 2013 Nov; 105(21):1656-66. PubMed ID: 24123960
[TBL] [Abstract][Full Text] [Related]
3. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
4. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
5. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
7. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
8. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.
Rauh-Hain JA; Pepin KJ; Meyer LA; Clemmer JT; Lu KH; Rice LW; Uppal S; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Dec; 126(6):1198-1206. PubMed ID: 26551187
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer.
Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2016 Oct; 128(4):761-70. PubMed ID: 27607873
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
11. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States.
Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962
[TBL] [Abstract][Full Text] [Related]
12. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Greenwald ZR; Huang LN; Wissing MD; Franco EL; Gotlieb WH
Cancer; 2017 May; 123(9):1545-1554. PubMed ID: 28026855
[TBL] [Abstract][Full Text] [Related]
13. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.
Sud S; Holmes J; Eblan M; Chen R; Jones E
Gynecol Oncol; 2018 Feb; 148(2):349-356. PubMed ID: 29276059
[TBL] [Abstract][Full Text] [Related]
15. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
16. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
Felix AS; Bower JK; Pfeiffer RM; Raman SV; Cohn DE; Sherman ME
Int J Cancer; 2017 Feb; 140(3):555-564. PubMed ID: 27741565
[TBL] [Abstract][Full Text] [Related]
17. Association Between Metabolic Syndrome and Endometrial Cancer Survival in a SEER-Medicare Linked Database.
Jin J; Dalwadi SM; Masand RP; Hall TR; Anderson ML; Ludwig MS
Am J Clin Oncol; 2020 Jun; 43(6):411-417. PubMed ID: 32205571
[TBL] [Abstract][Full Text] [Related]
18. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
[TBL] [Abstract][Full Text] [Related]
19. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
Rydzewski NR; Strohl AE; Donnelly ED; Kanis MJ; Lurain JR; Nieves-Neira W; Strauss JB
Cancer; 2016 Dec; 122(23):3724-3731. PubMed ID: 27509082
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
